Osiris Therapeutics to Present at Barclays Capital Global Healthcare … – PR Inside

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today that C. Randal Mills …

[Read the full article here]

Related News:
Osiris Therapeutics to Present at Piper Jaffray Conference
Osiris Therapeutics Reports Fourth Quarter and Full Year 2008 … – Phramalive.com
Osiris Therapeutics Completes Enrollment Of Stem Cell Trial For The Treatment Of Heart Attacks

Leave a Reply